Abstract

Introduction/BackgroundHigh-grade serous ovarian cancer (HGSOC) is typified by high degrees of genomic instability and heterogeneity, with the majority of patients eventually acquiring resistance to platinum chemotherapy. Matching the best treatment...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call